Comparison of the incidence of acute kidney injury during treatment with vancomycin in combination with piperacillin–tazobactam or with meropenem

The purpose of this study was to evaluate the observed incidence of acute kidney injury (AKI) in adult patients receiving either piperacillin–tazobactam (PT) and vancomycin or meropenem and vancomycin for at least 48 h. In this retrospective cohort study, we included adult patients with no known ren...

Full description

Bibliographic Details
Main Author: Majed S. Al Yami
Format: Article
Language:English
Published: Elsevier 2017-11-01
Series:Journal of Infection and Public Health
Online Access:http://www.sciencedirect.com/science/article/pii/S1876034117300199